Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
Qin G, Rai R, Zhang R, Su Y, Zhang B, Pan Y, Xiong R, Xie Y, Yang H, Kong X, Luo Z, Ruan X, Mo Y, Aftab O, Shahisanjeev, Jazib, Jiang W.
Qin G, et al. Among authors: kong x.
Oral Oncol. 2020 Jul;106:104704. doi: 10.1016/j.oraloncology.2020.104704. Epub 2020 Apr 21.
Oral Oncol. 2020.
PMID: 32330685